" class="no-js "lang="en-US"> Humphrey Gardner - Medtech Alert
Thursday, August 14, 2025
Humphrey Gardner

Humphrey Gardner

About Humphrey Gardner

Dr. Gardner holds a bachelor’s degree in Biochemistry and his medical degree from the University of Cambridge, and an MS in Bioinformatics from Brandeis University. He completed his residency in Anatomic Pathology at Beth Israel Hospital, Harvard Medical School, and postdoctoral training at Whitehead Institute, Massachusetts Institute of Technology (MIT).

Dr. Gardner is an expert in oncology, rheumatology, and infectious disease. He published approximately one hundred papers in international academic journals, and has been an active influential speaker at international conferences. He is also a fellow of the College of American Pathologists, and a member of American Society of Clinical Oncology, and has previously been a member of a variety of professional organizations including the European Society of Clinical Microbiology and Infectious Diseases and the American Association for Clinical Chemistry.

Related Story

Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer

April 14 2022

Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), today announced the appointment of Dr. Humphrey Gardner as Chief […]